Navigation Links
Certain breast cancer patients worry excessively about recurrence
Date:3/27/2011

A new study has found that certain types of women with early stage breast cancer are vulnerable to excessive worrying about cancer recurrence. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also indicates that worrying about cancer recurrence can compromise patients' medical care and quality of life.

Thanks to recent medical advances, most women who are diagnosed with early stage breast cancer have a low risk for cancer recurrence. Despite an optimistic future, many of these women report that they worry that their cancer will come back. While some worry about cancer recurrence is understandable, for some women these worries can be so strong that they have an impact on what treatments women choose, how often they seek care, and their quality of life as cancer survivors.

Nancy Janz, PhD, of the University of Michigan School of Public Health in Ann Arbor led a study that investigated whether worry about recurrence was related to race and ethnicity, acculturation (the process by which members of one cultural group adopt the beliefs and behaviors of another group), clinical and treatment factors, and how women viewed their experience in the health care system while being treated for breast cancer. The researchers studied 2,290 women with non-metastatic breast cancer who were diagnosed from June 2005 to February 2007 and reported to Detroit or Los Angeles cancer registries. A patient's level of worry was determined by assessing her concern about cancer returning to the same breast, the other breast, and spreading to other parts of the body.

Dr. Janz and her team found that women who had greater ease in understanding clinical information that was presented to them, who experienced fewer symptoms, and who received more coordinated care reported less worry about recurrence. Less acculturated Latina breast cancer patients were particularly vulnerable to high levels of worry, while African American patients had significantly less worry than other races. Other factors that were associated with more worry were being younger, being employed, experiencing more pain and fatigue, and undergoing radiation treatment.

"How much women worry about recurrence is often not aligned with their actual risk for cancer recurrence," said Dr. Janz. "We need to better understand the factors that increase the likelihood that women will worry and develop strategies and appropriate referrals to help women with excessive worry," she added. Dr. Janz noted that programs to assist women must be culturally sensitive and tailored to patients' differences in communication style, social support, and coping strategies. She also stressed the importance of appropriately presenting risk information to women with breast cancer so that they can understand their risk and effectively participate in treatment decisions.


'/>"/>

Contact: Jennifer Beal
healthnews@wiley.com
44-012-437-70633
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Study Questions Rise in Use of Certain Cholesterol Drugs
2. Treatment for alcohol dependence might work best in certain populations, research suggests
3. Aspirin May Protect Against Colorectal Cancer -- But Only in Certain People
4. Limited lymph node removal for certain breast cancer does not appear to result in poorer survival
5. For-Profit Hospices May Prefer Certain Types of Patients: Study
6. Adult ADHD Often Precedes Certain Type of Dementia: Study
7. Certain Painkillers Appear to Boost Odds for Heart Attack
8. Certain Drug Combinations May Beat Back Aggressive Breast Cancer
9. Certain Breast Cancer Drugs Linked With Heart Risks in Older Women
10. Certain Formulations of Omega-3s Might Help With Depression
11. Diagnosis uncertainty increases anxiety in patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... ... 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the 2017 ... , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: